Tianjin Zhongxin Pharmaceutical Analyst Reports

SGX Listed Stock

TIANJIN ZHONG XIN PHARM GROUP (SGX:T14)



TIANJIN ZHONG XIN PHARM GROUP (SGX:T14) has changed the issuer name / code to TIANJIN PHARM DA REN TANG GRP (SGX:T14) with effect from 2022-05-24.

See TIANJIN PHARM DA REN TANG GRP (SGX:T14)'s analyst reports.


TIANJIN ZHONG XIN PHARM GROUP (SGX:T14) @ SGinvestors.io
USD ***.**
-----
Share Price as of: -
Market / ISIN Code: SGX Mainboard /
Sector / Industry Group / Industry: Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals


Tianjin Zhongxin Pharmaceutical Analyst Research ReportsTIANJIN ZHONG XIN PHARM GROUP Analyst Research Reports SGX Listed Tianjin Zhongxin Pharmaceutical (SGX:T14) Analyst Research Reports T14.SI Analyst Research Reports



Analyst Report
Analysts Say
Tianjin Zhongxin Pharmaceutical Analyst Reports








Your Say









SGX Stock / REIT Search

Advertisement

Trust Bank Referral Code

Advertisement